SPL 1.00% 9.9¢ starpharma holdings limited

Without any human trial evidence/data. But swirling in...

  1. 59 Posts.
    lightbulb Created with Sketch. 13
    Without any human trial evidence/data. But swirling in regulatory controversy. And led by an amateurish BOD/management. You work out the odds.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.